Cargando…
In silico analysis of the solute carrier (SLC) family in cancer indicates a link among DNA methylation, metabolic adaptation, drug response, and immune reactivity
Introduction: The oncogenic transformation is driven by genetic and epigenetic alterations influencing cancer cell fate. These alterations also result in metabolic reprogramming by modulating the expression of membrane Solute Carrier (SLC) transporters involved in biomolecules trafficking. SLCs act...
Autores principales: | Lavoro, Alessandro, Falzone, Luca, Tomasello, Barbara, Conti, Giuseppe Nicolò, Libra, Massimo, Candido, Saverio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308049/ https://www.ncbi.nlm.nih.gov/pubmed/37397501 http://dx.doi.org/10.3389/fphar.2023.1191262 |
Ejemplares similares
-
Novel Insights into Epigenetic Regulation of IL6 Pathway: In Silico Perspective on Inflammation and Cancer Relationship
por: Candido, Saverio, et al.
Publicado: (2021) -
Bioinformatic analysis of the LCN2–SLC22A17–MMP9 network in cancer: The role of DNA methylation in the modulation of tumor microenvironment
por: Candido, Saverio, et al.
Publicado: (2022) -
Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer
por: Leone, Gian Marco, et al.
Publicado: (2023) -
Co-Occurrence of Interleukin-6 Receptor Asp358Ala Variant and High Plasma Levels of IL-6: An Evidence of IL-6 Trans-Signaling Activation in Deep Vein Thrombosis (DVT) Patients
por: Salemi, Rossella, et al.
Publicado: (2022) -
MMP-9 as a Candidate Marker of Response to BRAF Inhibitors in Melanoma Patients With BRAF(V600E) Mutation Detected in Circulating-Free DNA
por: Salemi, Rossella, et al.
Publicado: (2018)